Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial
Abstract
Citations
-
1 2 6
CrossRef
-
0
Web of Science
-
1 3 4
Scopus
Authors (25)
Cite as
Full text
full text is not available in portal
Details
- Category:
- Magazine publication
- Type:
- Magazine publication
- Published in:
-
LANCET ONCOLOGY
no. 17,
edition 3,
pages 319 - 331,
ISSN: 1470-2045 - ISSN:
- 1470-2045
- Publication year:
- 2016
- DOI:
- Digital Object Identifier (open in new tab) 10.1016/s1470-2045(15)00559-8
- Verified by:
- No verification
seen 84 times